These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
838 related articles for article (PubMed ID: 28365132)
1. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges. Syn NL; Wang L; Chow EK; Lim CT; Goh BC Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132 [TBL] [Abstract][Full Text] [Related]
2. Designer exosomes as next-generation cancer immunotherapy. Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074 [TBL] [Abstract][Full Text] [Related]
3. The application of exosomes as a nanoscale cancer vaccine. Tan A; De La Peña H; Seifalian AM Int J Nanomedicine; 2010 Nov; 5():889-900. PubMed ID: 21116329 [TBL] [Abstract][Full Text] [Related]
4. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications. Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837 [TBL] [Abstract][Full Text] [Related]
6. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges. Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119 [TBL] [Abstract][Full Text] [Related]
8. A systematic approach to exosome-based translational nanomedicine. Hood JL; Wickline SA Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):458-67. PubMed ID: 22648975 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Viaud S; Théry C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput N Cancer Res; 2010 Feb; 70(4):1281-5. PubMed ID: 20145139 [TBL] [Abstract][Full Text] [Related]
10. Post isolation modification of exosomes for nanomedicine applications. Hood JL Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448 [TBL] [Abstract][Full Text] [Related]
11. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment. Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168 [TBL] [Abstract][Full Text] [Related]
12. Cancer Nanomedicine: Lessons for Immuno-Oncology. Sengupta S Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932 [TBL] [Abstract][Full Text] [Related]
13. On the Choice of the Extracellular Vesicles for Therapeutic Purposes. Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425 [TBL] [Abstract][Full Text] [Related]
14. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy. Mukherjee A; Bisht B; Dutta S; Paul MK Acta Pharmacol Sin; 2022 Nov; 43(11):2759-2776. PubMed ID: 35379933 [TBL] [Abstract][Full Text] [Related]
15. Artificial exosomes for translational nanomedicine. Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440 [TBL] [Abstract][Full Text] [Related]
16. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation. Alfonsi R; Grassi L; Signore M; Bonci D Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798 [TBL] [Abstract][Full Text] [Related]
17. Exosome-based anticancer vaccines: From Bench to bedside. Zhao G; Wang Y; Xing S; Jiang Y; Ding J; Cai Y; Ma P; Miao H; Fang Y; Jiang N; Cui D; Yu Y; Tang Q; Wang S; Li N Cancer Lett; 2024 Jul; 595():216989. PubMed ID: 38825162 [TBL] [Abstract][Full Text] [Related]
18. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications. Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095 [TBL] [Abstract][Full Text] [Related]